oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes | NEJM Comparative cardiovascular outcomes of semaglutide
Description
Weekly journal scan: tirzepatide SURMOUNTs obesity-related obstructive sleep apnoea
If moving from retatrutide to a lower-potency medication for maintenance, the reduced appetite suppression makes it easier to consume adequate protein, which naturally supports lean tissue recovery
Some people report less sensitivity in the thigh compared to the abdomen
16: S4S14
prioritize high-protein foods at every meal even when appetite is suppressed
And so just as theres not one type of diabetes or one cause for high blood pressure, theres not one type of obesity
